Bill Sponsor
Senate Bill 5206
118th Congress(2023-2024)
United States Pharmaceutical Supply Chain Review Act
Introduced
Introduced
Introduced in Senate on Sep 25, 2024
Overview
Text
Introduced
Sep 25, 2024
Latest Action
Sep 25, 2024
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5206
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Massachusetts
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary
Unavailable
Text (1)
September 25, 2024
Actions (2)
09/25/2024
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
09/25/2024
Introduced in Senate
Graphics
S.5206 118 United States Pharmaceutical Supply Chain Review Act
Public Record
Record Updated
Nov 4, 2024 3:00:21 PM